| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Small Business > Going Public: Now that You Have Successfully Made the Transition, What Do You Do? |
|
Subjects - Going Public: Now that You Have Successfully Made the Transition, What Do You Do?
Ok, you have successfully accomplished your dream of being the CEO of a public company. The stock of your company has a symbol and you are continually going to the computer to check the pr According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ice, you tell all your relatives and friends and you even tried to encourage them to buy the stock. You think your job is done, you selected an excellent market maker, you released an anno ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in uncement to the financial news media, but nothing is happening. If you are playing basketball and you make a three point shot do you sit on the court and admire your accomplishment or do lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. you go back and play defense? You do not have to manage the price of the stock like so many CEO of newly listed companies try to do, instead you go back to work and use the newly acquired here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe tools to grow your company. As a public company now you can now approach investors and let them now that you are working hard to grow the company but if they should need some liquidity th d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e market will provide it. You can now go out and retain a public relations firm and make sure that the investors know who you are and where to find you. But before you do this make sure th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc at you can afford the investors relations company, otherwise you will have to learn how to promote your company and stay within the legal boundaries as define by the regulators. You will n easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi w be able to attract and retain more highly qualified personnel by offering stock options and bonuses. Because you will need them. With the privilege of being a public company comes added r nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically esponsibility, so you must have highly competent personnel to meet the challenge.
Now as a public company you have received a tool to help you grow your company. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ As a public company you have stock with a known market value, The stock can be use for acquisitions. Acquisitions must be made in a prudent manner, you have to make sure that the compani ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi es have synergy and you are acquiring something of value the will make your company larger and more prosperous. I won’t mention any names but I know of several franchising companies that ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a have acquired many different franchises some as many as 600 different franchises. But all they have done is acquired names of different known franchises because the the earnings have not i dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod mproved nor has the price of the stock. These companies are trading for pennies with little or no chance for improvement since they have a ton of stock outstanding. That is one reason th cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin at acquisition must be done prudently and selectively, and not just for the sake of getting the name of your company in the papers. You must have a business plan and the fortitude to stick tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen by it regardless of the critics, the business plan must be flexible enough to allow you to make changes when necessary. This plan must be in writing and available to potential investors. If t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel you approach investors without a business plan you will have a difficult time trying to convince them that you are offering a good investment. A business plan shows investors that you kno ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust w what you are doing and where you want to take the company. A lack of a business plan indicate a lack of direction, some entrepreneurs are big dreamers but their plans tend to swing all o y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ver the place causing them change direction every other week. Begin by designing a strategy for the future, taking into consideration what you want to accomplish after you take your compan . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de y public. If you have a plan your chances of success will be greatly improved. By being successful from the beginning opportunities will present themselves almost immediately and give you elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip a head start on the competition. If you are thinking of going public visit our website: www.genesiscorporateadvisors.com tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Change Management Reversals; Are They Possible Acquiring Business Grants the Easy Way Information on an Exhibition Stand Contractor
|